Physician

Pranjal Sharma, M.B.B.S.

According to 2025 Medicare claims, Pranjal Sharma, M.B.B.S. (NPI: 1619285723) practices nephrology in the Akron, OH market, with the plurality of this provider's patient population coming from Summit, OH. This provider's primary affiliated billing organization is PREMIER RENAL CARE ASSOCIATES LLC (NPI: 1326780719; TIN: 880655493) and primary practice location at 44304-1407. Sharma is affiliated with the ACO West Virginia (ACO ID: A3563), participating under the MSSP model.

Sharma's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 315 traditional Medicare patients, billed 1,620 HCPCS/CPT codes, and received $120,961 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 1,238 prescription claims across 324 beneficiaries totaling $155,233 in drug costs, led by Farxiga (Dapagliflozin Propanediol). 2022 DME data shows 47 claims. Open Payments data shows 23 records totaling $531. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $28,789 and ending at $120,961. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $2,957 to $155,233. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	174	355	$28,789
2017	392	1,122	$84,716
2018	443	1,443	$103,112
2019	316	796	$55,755
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	288	901	$57,049
2023	283	1,190	$90,257
2024	315	1,620	$120,961

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	45	183	$2,957
2016	83	241	$5,967
2017	125	312	$19,803
2018	155	348	$13,466
2019	107	218	$6,790
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	142	390	$49,188
2023	149	531	$77,067
2024	324	1,238	$155,233

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	47	$2,534
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	105	122	$135
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	113	252	$92
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	84	148	$91
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	116	235	$61
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	114	210	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Farxiga	Dapagliflozin Propanediol	48	3,016	$55,324
Kerendia	Finerenone	23	1,290	$27,223
Lokelma	Sodium Zirconium Cyclosilicate	23	612	$9,524
Jardiance	Empagliflozin	12	420	$7,969
Sevelamer Carbonate	Sevelamer Carbonate	45	2,880	$5,893

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	23	$531	CALLIDITAS THERAPEUTICS US INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Pranjal Sharma, M.B.B.S.?

Tedicare shows public-source Medicare data for Pranjal Sharma, M.B.B.S. (NPI 1619285723), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Pranjal Sharma, M.B.B.S. have ACO affiliation data?

Pranjal Sharma, M.B.B.S. is shown with ACO affiliation data for ACO West Virginia (MSSP, ACO ID A3563).

What billing organization is linked to Pranjal Sharma, M.B.B.S.?

Pranjal Sharma, M.B.B.S. is linked to PREMIER RENAL CARE ASSOCIATES LLC (billing NPI 1326780719) in the available physician profile data.

Does Pranjal Sharma, M.B.B.S. have Open Payments data?

Pranjal Sharma, M.B.B.S. has 23 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.